Plain-English translation of NCT06555809 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how infants' bodies process artesunate, a medication used to treat severe malaria. This study is collecting a small number of blood samples during and after treatment to understand how quickly the medicine works and how it moves through the body. The goal is to make sure this treatment is as safe and effective as possible for the youngest patients.
While this medication is already being used to treat malaria in infants, doctors need better information about how babies' bodies handle it differently than older children or adults. Understanding these differences will help doctors give the right doses and ensure the treatment works safely for the smallest and most vulnerable patients.
You likely qualify if…
You likely don't qualify if…
If your infant qualifies, a small amount of blood (up to 4 samples total) will be collected during the first 48 hours of treatment, taken at the same time as routine hospital blood tests so there are no extra needle sticks. The research team will also review your child's medical records and collect one additional standard blood test about one month after treatment ends to check for anemia and other health markers.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
France